We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLDB icon
12401
PUT
Solid Biosciences
SLDB
$1.08B
$12K ﹤0.01%
1,260
+267
+27% +$2.77K
UBX
12402
PUT
DELISTED
Unity Biotechnology
UBX
$12K ﹤0.01%
2,140
+30
+1% +$250
QNTM
12403
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$130
$12K ﹤0.01%
225
-423
-65% -$25.4K
QNTM
12404
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$130
$12K ﹤0.01%
235
-74
-24% -$4.44K
ZYNE
12405
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$12K ﹤0.01%
10,867
-151,779
-93% -$193K
UTAAW
12406
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$12K ﹤0.01%
+31,771
New +$16.1K
NYMX
12407
DELISTED
Nymox Pharmaceutical Corp
NYMX
$12K ﹤0.01%
26,527
-38,236
-59% -$35.2K
PNTM.WS
12408
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$12K ﹤0.01%
96,320
+23,323
+32% +$5.14K
TYME
12409
PUT
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$12K ﹤0.01%
41,900
-3,800
-8% -$1.1K
PBLA
12410
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$12K ﹤0.01%
+1
New +$37K
CATX icon
12411
Perspective Therapeutics
CATX
$364M
$11K ﹤0.01%
3,533
+1,714
+94% +$5.24K
CNTB
12412
Connect Biopharma Holdings
CNTB
$149M
$11K ﹤0.01%
+13,110
New +$19.3K
CRVS icon
12413
CALL
Corvus Pharmaceuticals
CRVS
$1.26B
$11K ﹤0.01%
11,100
-14,400
-56% -$17.7K
EBON icon
12414
PUT
Ebang International Holdings
EBON
$13.9M
$11K ﹤0.01%
933
-7,990
-90% -$195K
CBIO
12415
Crescent Biopharma
CBIO
$660M
$11K ﹤0.01%
176
-300
-63% -$22.2K
KALA icon
12416
KALA BIO
KALA
$15.9M
$11K ﹤0.01%
15
-19
-56% -$29.8K
SVRN
12417
OceanPal Inc
SVRN
$16.2M
0
SANW
12418
PUT
DELISTED
S&W Seed Co
SANW
$11K ﹤0.01%
574
-242
-30% -$6.31K
XOSWW
12419
DELISTED
Xos Inc Warrants
XOSWW
$11K ﹤0.01%
+51,150
New +$16.9K
YCBD icon
12420
CALL
cbdMD
YCBD
$5.8M
$11K ﹤0.01%
67
-127
-65% -$30.1K
QTT
12421
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$11K ﹤0.01%
+11,000
New +$12.3K
RKLY.WS
12422
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
$11K ﹤0.01%
+34,839
New +$17.9K
PV.WS
12423
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$11K ﹤0.01%
+68,774
New +$17.8K
AVPTW
12424
DELISTED
AvePoint Inc Warrant
AVPTW
$10K ﹤0.01%
+15,335
New +$13K
CIFRW
12425
DELISTED
Cipher Mining Warrant
CIFRW
$10K ﹤0.01%
50,000

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.